FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205212663> ?p ?o ?g. }

• W4205212663 endingPage "e2141898" @default.
• W4205212663 startingPage "e2141898" @default.
• W4205212663 abstract "<h3>Importance</h3> Intense interest exists in novel ω-3 formulations with high bioavailability to reduce blood triglyceride (TG) levels. <h3>Objective</h3> To determine the phase 3 efficacy and safety of a naturally derived krill oil with eicosapentaenoic acid and docosahexaenoic acid as both phospholipid esters (PLs) and free fatty acids (FFAs) (ω-3–PL/FFA [CaPre]), measured by fasting TG levels and other lipid parameters in severe hypertriglyceridemia. <h3>Design, Setting, and Participants</h3> This study pooled the results of 2 identical randomized, double-blind, placebo-controlled trials. TRILOGY 1 (Study of CaPre in Lowering Very High Triglycerides) enrolled participants at 71 US centers from January 23, 2018, to November 20, 2019; TRILOGY 2 enrolled participants at 93 US, Canadian, and Mexican centers from April 6, 2018, to January 9, 2020. Patients with fasting TG levels from 500 to 1500 mg/dL, with or without stable treatment with statins, fibrates, or other agents to lower cholesterol levels, were eligible to participate. <h3>Interventions</h3> Randomization (2.5:1.0) to ω-3–PL/FFA, 4 g/d, vs placebo (cornstarch) for 26 weeks. <h3>Main Outcomes and Measures</h3> The primary outcome was the mean percentage of change in TG levels at 12 weeks; persistence at 26 weeks was the key secondary outcome. Other prespecified secondary outcomes were effects on levels of non–high-density lipoprotein cholesterol (non–HDL-C), very-low-density lipoprotein cholesterol (VLDL-C), HDL-C, and low-density lipoprotein cholesterol (LDL-C); safety and tolerability; and TG level changes in prespecified subgroups. <h3>Results</h3> A total of 520 patients were randomized, with a mean (SD) age of 54.9 (11.2) years (339 men [65.2%]), mean (SD) body mass index of 31.5 (5.1), and baseline mean (SD) TG level of 701 (222) mg/dL. Two hundred fifty-six patients (49.2%) were of Hispanic or Latino ethnicity; 275 (52.9%) had diabetes; and 248 (47.7%) were receiving statins. In the intention-to-treat analysis, TG levels were reduced by 26.0% (95% CI, 20.5%-31.5%) in the ω-3–PL/FFA group and 15.1% (95% CI, 6.6%-23.5%) in the placebo group at 12 weeks (mean treatment difference, −10.9% [95% CI, −20.4% to −1.5%];<i>P</i> = .02), with reductions persisting at 26 weeks (mean treatment difference, −12.7% [95% CI, −23.1% to −2.4%];<i>P</i> = .02). Compared with placebo, ω-3–PL/FFA had no significant effect at 12 weeks on mean treatment differences for non–HDL-C (−3.2% [95% CI, −8.0% to 1.6%];<i>P</i> = .18), VLDL-C (−3.8% [95% CI, −12.2% to 4.7%];<i>P</i> = .38), HDL-C (0.7% [95% CI, −3.7% to 5.1%];<i>P</i> = .77), or LDL-C (4.5% [95% CI, −5.9% to 14.8%];<i>P</i> = .40) levels; corresponding differences at 26 weeks were −5.8% (95% CI, −11.3% to −0.3%;<i>P</i> = .04) for non–HDL-C levels, −9.1% (95% CI, −21.5% to 3.2%;<i>P</i> = .15) for VLDL-C levels, 1.9% (95% CI, −4.8% to 8.6%;<i>P</i> = .57) for HDL-C levels, and 6.3% (95% CI, −12.4% to 25.0%;<i>P</i> = .51) for LDL-C levels. Effects on the primary end point did not vary significantly by age, sex, race and ethnicity, country, qualifying TG level, diabetes, or fibrate use but tended to be larger among patients taking statins or cholesterol absorption inhibitors at baseline (mean treatment difference, −19.5% [95% CI, −34.5% to −4.6%];<i>P</i>= .08 for interaction) and with lower (less than median) baseline blood eicosapentaenoic acid plus docosahexaenoic acid levels (−19.5% [95% CI, −33.8% to −5.3%];<i>P</i> = .08 for interaction). ω-3–PL/FFA was well tolerated, with a safety profile similar to that of placebo. <h3>Conclusions and Relevance</h3> This study found that ω-3 –PL/FFA, a novel krill oil–derived ω-3 formulation, reduced TG levels and was safe and well tolerated in patients with severe hypertriglyceridemia. <h3>Trial Registration</h3> ClinicalTrials.gov Identifiers:NCT03398005andNCT03361501" @default.
• W4205212663 created "2022-01-26" @default.
• W4205212663 creator A5001526330 @default.
• W4205212663 creator A5001764540 @default.
• W4205212663 creator A5002781938 @default.
• W4205212663 creator A5002852988 @default.
• W4205212663 creator A5003675274 @default.
• W4205212663 creator A5005982472 @default.
• W4205212663 creator A5006099075 @default.
• W4205212663 creator A5006516877 @default.
• W4205212663 creator A5007087704 @default.
• W4205212663 creator A5007251713 @default.
• W4205212663 creator A5007463081 @default.
• W4205212663 creator A5008054334 @default.
• W4205212663 creator A5008908371 @default.
• W4205212663 creator A5009062765 @default.
• W4205212663 creator A5009366919 @default.
• W4205212663 creator A5009444086 @default.
• W4205212663 creator A5009474919 @default.
• W4205212663 creator A5010738559 @default.
• W4205212663 creator A5011394839 @default.
• W4205212663 creator A5011403969 @default.
• W4205212663 creator A5011470127 @default.
• W4205212663 creator A5011880332 @default.
• W4205212663 creator A5011994505 @default.
• W4205212663 creator A5012187065 @default.
• W4205212663 creator A5012538169 @default.
• W4205212663 creator A5013036949 @default.
• W4205212663 creator A5013260005 @default.
• W4205212663 creator A5014360640 @default.
• W4205212663 creator A5016382751 @default.
• W4205212663 creator A5019469768 @default.
• W4205212663 creator A5020101175 @default.
• W4205212663 creator A5020866830 @default.
• W4205212663 creator A5021673405 @default.
• W4205212663 creator A5021847980 @default.
• W4205212663 creator A5021901825 @default.
• W4205212663 creator A5022739394 @default.
• W4205212663 creator A5023016850 @default.
• W4205212663 creator A5023176413 @default.
• W4205212663 creator A5023350293 @default.
• W4205212663 creator A5023907367 @default.
• W4205212663 creator A5024085615 @default.
• W4205212663 creator A5026115084 @default.
• W4205212663 creator A5028173142 @default.
• W4205212663 creator A5028789803 @default.
• W4205212663 creator A5028867550 @default.
• W4205212663 creator A5029272667 @default.
• W4205212663 creator A5030025475 @default.
• W4205212663 creator A5032023438 @default.
• W4205212663 creator A5032517154 @default.
• W4205212663 creator A5032527746 @default.
• W4205212663 creator A5032787489 @default.
• W4205212663 creator A5033012418 @default.
• W4205212663 creator A5033014448 @default.
• W4205212663 creator A5033341046 @default.
• W4205212663 creator A5033387468 @default.
• W4205212663 creator A5033876610 @default.
• W4205212663 creator A5034084520 @default.
• W4205212663 creator A5034774303 @default.
• W4205212663 creator A5035006405 @default.
• W4205212663 creator A5035358062 @default.
• W4205212663 creator A5036030375 @default.
• W4205212663 creator A5036181064 @default.
• W4205212663 creator A5036190097 @default.
• W4205212663 creator A5036773414 @default.
• W4205212663 creator A5037529101 @default.
• W4205212663 creator A5039544231 @default.
• W4205212663 creator A5039911080 @default.
• W4205212663 creator A5040058418 @default.
• W4205212663 creator A5040644218 @default.
• W4205212663 creator A5042595043 @default.
• W4205212663 creator A5043036124 @default.
• W4205212663 creator A5043048639 @default.
• W4205212663 creator A5043063539 @default.
• W4205212663 creator A5043658721 @default.
• W4205212663 creator A5043837364 @default.
• W4205212663 creator A5044643037 @default.
• W4205212663 creator A5045191139 @default.
• W4205212663 creator A5045961850 @default.
• W4205212663 creator A5045997496 @default.
• W4205212663 creator A5046254738 @default.
• W4205212663 creator A5047101821 @default.
• W4205212663 creator A5047151278 @default.
• W4205212663 creator A5047775356 @default.
• W4205212663 creator A5048445090 @default.
• W4205212663 creator A5048603320 @default.
• W4205212663 creator A5049534125 @default.
• W4205212663 creator A5049608245 @default.
• W4205212663 creator A5049894611 @default.
• W4205212663 creator A5050413753 @default.
• W4205212663 creator A5050655356 @default.
• W4205212663 creator A5051023781 @default.
• W4205212663 creator A5051058769 @default.
• W4205212663 creator A5052461898 @default.
• W4205212663 creator A5052649775 @default.
• W4205212663 creator A5053191013 @default.
• W4205212663 creator A5053948090 @default.

• next